Boston Partners
RDY icon

Boston Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Boston Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-34,240
Closed -$295K – 734
2014
Q2 		$295K Hold
34,240
– – ﹤0.01% 699
2014
Q1 		$301K Hold
34,240
– – ﹤0.01% 699
2013
Q4 		$281K Hold
34,240
– – ﹤0.01% 694
2013
Q3 		$259K Buy
+34,240
New +$249K ﹤0.01% 680

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Boston Partners's RDY Position: Q3 2014 in Review

Boston Partners sold out of Dr. Reddy's Laboratories (RDY) in Q3 2014, closing a stake of 34,240 shares — an estimated $295K sold.

Boston Partners first reported a position in RDY in Q3 2013 and held it in 4 quarters. The position peaked at $301K in Q1 2014. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

  • Boston Partners reported no remaining Dr. Reddy's Laboratories position as of Q3 2014 after selling out during the quarter.
  • Boston Partners sold 34,240 Dr. Reddy's Laboratories shares in Q3 2014, an estimated $295K.
  • Boston Partners first reported a position in Dr. Reddy's Laboratories in Q3 2013 and held it in 4 quarters.
  • Boston Partners's Dr. Reddy's Laboratories position peaked at $301K in Q1 2014.
  • 159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on Boston Partners's 13F filing for Q3 2014, filed 12 Nov 2014.